Bayer and Iambic collaborate to advance drug discovery with AI
Iambic official newsroom · Indexed industry source record · Source published: Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:35 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Bayer and Iambic collaborate to advance drug discovery with AI Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research and development portfolio by harnessing AI to accelerate drug discovery Berlin, Germany and San Diego, USA, June 22, 2026 – Bayer and Iambic Therapeutics Inc., a clinica
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.